PROCEPT BioRobotics Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PROCEPT BioRobotics Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
  • PROCEPT BioRobotics Corp Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.99M, a 56.5% increase year-over-year.
  • PROCEPT BioRobotics Corp Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $24.5M, a 64.3% increase year-over-year.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2023 was $19.1M, a 85.1% increase from 2022.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2022 was $10.3M, a 172% increase from 2021.
  • PROCEPT BioRobotics Corp annual Share-based Payment Arrangement, Expense for 2021 was $3.8M, a 74.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $24.5M $7.99M +$2.88M +56.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $21.7M $6.26M +$2.53M +68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $19.1M $4.98M +$2.1M +72.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $17M $5.33M +$2.1M +65.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $14.9M $5.1M +$2.43M +90.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $12.5M $3.72M +$2.17M +140% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $10.3M $2.88M +$1.39M +92.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $8.95M $3.23M +$2.3M +249% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $6.65M $2.68M +$1.95M +269% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $4.7M $1.55M +$902K +139% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $3.8M $1.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $925K +$362K +64.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $725K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $650K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 $563K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.